all - Opinion Summaries
Page 78 of 88
Showing Result 771 - 780 of 874
| Description | Date | Docket # |
|---|---|---|
GENEVA PHARM. TECH. CORP. v. BARR LAB. INC.United States Second Circuit
Antitrust & Trade Regulation, Drugs & BiotechDismissal of plaintiff's Antitrust claims, alleging that a competing manufacturer and its supplier conspired to restrain trade and monopolize the... |
10/18/2004 | 02-9222, 02-9346 |
GARCIA v. WYETH-AYERST LAB.United States Sixth Circuit
Constitutional Law, Drugs & Biotech, Health Law, Injury & Tort Law, Product LiabilityIn a products liability case, summary judgment for defendant on the basis of statutory immunity provided by a Mich. Comp. Laws section 600.2946(5) is... |
10/07/2004 | 03-1712 |
IN RE: DIET DRUGS PRODUCTS LIABILITY LITIGATIONUnited States Third Circuit
Class Actions, Drugs & Biotech, Injury & Tort Law, Product LiabilityIn a diet drug product liability case, an amendment to a settlement agreement was properly approved by the district court as fair and reasonable since... |
10/05/2004 | 03-2025, 03-2063, 03-2072 |
US v. OMNICARE INC.United States Third Circuit
Drugs & Biotech, Health LawThere is no False Claims Act liability for a failure to reimburse Medicaid for recycled medications based on a lack of legal authority requiring... |
09/01/2004 | 03-2187 |
DOE v. BAXTER HEALTHCAREUnited States Eighth Circuit
Drugs & Biotech, Health Law, Injury & Tort Law, Product LiabilityPlaintiffs' suit, alleging that defendants negligently infected their son with HIV, is dismissed where plaintiffs could not prove who caused the... |
08/24/2004 | 03-2651 |
MOSS V. MERCK & CO.United States Fifth Circuit
Drugs & Biotech, Health Law, Injury & Tort LawDismissal of plaintiff's tort claims is reversed where the district court incorrectly determined that defendant is a vaccine manufacturer entitled to... |
08/17/2004 | 03-30958 |
IN RE WALLACHUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentPlaintiffs unsuccessfully appeal the rejection of their claims for a patent application on grounds that plaintiffs did not describe the genetic... |
08/11/2004 | 03-1327 |
IN RE CIPRO CASES I AND IICalifornia Court of Appeal
Class Actions, Drugs & Biotech, Health LawThe trial court did not abuse its discretion in granting an order for class certification, however, the trial court erred where the class is overbroad... |
08/05/2004 | D043543 |
GLAXO GROUP v. APOTEX, INC.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn a patent dispute, defendant unsuccessfully appealed the district court's determination that its abbreviated new drug application (ANDA)infringes... |
07/27/2004 | 03-1575 |
ELI LILLY v. ARADIGM CORP.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn a patent dispute, the Court reversed the district court's denial of defendant's motion for judgment as a matter of law on a joint inventorship... |
07/20/2004 | 03-1336 |
Results 771 to 780 of 874